How do you advise a patient with VTE on indefinite anticoagulants regarding the Ad26.COV2.S Johnson & Johnson/Janssen COVID vaccine?
Answer from: Medical Oncologist at Community Practice
The thrombotic events seen with the Ad26.COV2.S vaccine do not appear to be associated with a prior history of clotting events. It seems to be a different entity, similar to heparin induced thrombocytopenia, with clinical presentation of thrombosis and thrombocytopenia. Muir et al., PMID 338527...
Comments
at UCLA Medical Center Thank you so much, Dr. @Lori J. Rosenstein --...
Medical Oncologist at Ironwood Cancer & Research Center Thank you so much, Dr. @Lori J. Rosenstein. This i...
Thank you so much, Dr. @Lori J. Rosenstein --...
Thank you so much, Dr. @Lori J. Rosenstein. This i...